Parkinson disease trials in China

In China 102 Also abroad 823

102 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease
Where
Shanghai
Age
18 years to 70 years
People
90
Run by
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
See details and how to joinNCT07166757
No phaseEnrolling by invitation
A Randomized Double-Blind Active-Controlled Crossover Trial of Respiratory-Gated Versus Non-Gated Transcutaneous Auricular Vagus Nerve Stimulation for the Treatment of Motor and Non-Motor Symptoms in Parkinson's Disease
Where
Hefei
Age
40 years to 80 years
People
30
Run by
Anhui Medical University
See details and how to joinNCT06642454
No phaseTaking people
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
Where
Shanghai
Age
50 years to 80 years
People
56
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06002581
No phaseNot yet taking people in China
Subthalamic Nucleus Versus Globus Pallidal Internus Deep Brain Stimulation for Parkinson Disease
Where
Beijing, Dalian, Hangzhou, Jinan, Nanjing, Shanghai, Tianjin, Wuhan
Age
22 years to 75 years
People
86
Run by
Zhang Jianguo
See details and how to joinNCT07250685
No phaseTaking people
Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease
Where
Hangzhou
Age
40 years to 80 years
People
200
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07244640
No phaseTaking people
Respiratory-gated Transcutaneous Auricular Vagus Nerve Stimulation for Improving Apathy in Parkinson's Disease
Where
Hefei
Age
40 years to 90 years
People
60
Run by
Anhui Medical University
See details and how to joinNCT07118956
Phase 2Taking people
The Study is Being Conducted to Evaluate the Safety and Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes
Where
Guangzhou
Age
30 years to 85 years
People
84
Run by
Guangzhou Novaken Pharm Co., Ltd.
See details and how to joinNCT07156773
Phase 1Taking people
Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease
Where
Shanghai
Age
40 years to 65 years
People
12
Run by
Ruijin Hospital
See details and how to joinNCT07157345
No phaseTaking people
Clinical Efficacy and Mechanism of tDCS for Dysphagia in PD
Where
Hangzhou
Age
18 years to 100 years
People
58
Run by
Wang Ping
See details and how to joinNCT07153692
Early phase 1Taking people
Evaluation of GM101 Injection in Patients With Parkinson's Disease
Where
Changsha
Age
40 years to 70 years
People
10
Run by
Genemagic Biosciences Co., Ltd
See details and how to joinNCT07100171
Phase 1Taking people
A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR201 in the Treatment of Subjects With Parkinson's Disease
Where
Hefei
Age
40 years to 75 years
People
48
Run by
Nuwacell Biotechnologies Co., Ltd.
See details and how to joinNCT06978920
Early phase 1Not yet taking people in China
A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's Disease
Where
Shanghai
Age
40 years to 65 years
People
6
Run by
Ruijin Hospital
See details and how to joinNCT07085195
No phaseTaking people
Acupuncture and Moxibustion for Motor Symptoms in Early Parkinson's Disease
Where
Beijing
Age
30 years to 80 years
People
60
Run by
Jiani Wu
See details and how to joinNCT06874803
No phaseTaking people
Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
Where
Beijing
Age
18 years to 60 years
People
2,300
Run by
Xuanwu Hospital, Beijing
See details and how to joinNCT06092125
Phase 1Not yet taking people in China
hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases
Where
Beijing
Age
18 years to 80 years
People
120
Run by
Xuanwu Hospital, Beijing
See details and how to joinNCT06607900
No phaseTaking people
VIM+PTT MRgFUS for PD
Where
Beijing
Age
22 years and over
People
20
Run by
Chinese PLA General Hospital
See details and how to joinNCT07044973
Phase 2Not yet taking people in China
The Safety, Feasibility and Efficacy of NouvNeu001 for Parkinson's Disease
Where
Beijing
Age
50 years to 75 years
People
30
Run by
iRegene Therapeutics Co., Ltd.
See details and how to joinNCT07028632
No phaseTaking people
Efficacy and Safety of Entacapone Combined With Madopar in the Treatment of Early Parkinson's Disease: An Observational, Multicenter, Case-Control Study
Where
Nanning
Age
18 years to 80 years
People
216
Run by
Yousheng Xiao
See details and how to joinNCT06928519
No phaseTaking people
The Efficacy and Safety of Precision REpetitive Transcranial Magnetic Stimulation in Alleviating Motor Symptom in Parkinson's Disease
Where
Hefei
Age
40 years and over
People
290
Run by
Anhui Medical University
See details and how to joinNCT06383247
No phaseTaking people
Impact of Frequency-specific Subthalamic Nucleus Subregion Stimulation on Inhibitory Control in Parkinson's Disease
Where
Beijing
Age
40 years to 80 years
People
20
Run by
Beijing Tiantan Hospital
See details and how to joinNCT07022522
No phaseTaking people
Mechanism and Application of DBS in the Treatment of PD
Where
Beijing
Age
50 years to 70 years
People
60
Run by
Beijing Tiantan Hospital
See details and how to joinNCT06400017
No phaseNot yet taking people in China
Deep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia Patients
Where
Shanghai
Age
50 years to 80 years
People
85
Run by
RenJi Hospital
See details and how to joinNCT06978946
No phaseTaking people
Application of AI Technology for the Diagnosis and Treatment of Geriatric Diseases
Where
Jinan
Age
8 years to 100 years
People
460
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT06295263
No phaseTaking people
AI-Enhanced Optimization of Acute Levodopa Challenge Test
Where
Beijing
Age
50 years to 75 years
People
2,000
Run by
Beijing Tiantan Hospital
See details and how to joinNCT06949865
No phaseEnrolling by invitation
The Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) Targeting the Right Globus Pallidus Internus (GPi) for Motor Symptoms in Patients With PD
Where
Hefei
Age
50 years to 80 years
People
40
Run by
Yanghua Tian
See details and how to joinNCT06931483